The FDA has approved a new drug that not only treats a rare genetic disease that causes extremely high cholesterol levels, but does so using first-of-its-kind technology that has been enhanced ...

These factors are anticipated to achieve better patient adherence to the life-long treatment required to control LDL cholesterol." "As planned, the Lerodalcibep BLA has been submitted to the FDA ...